Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what vetting procedures are in place to ensure care agencies providing non UK workers in the care industry ensure the safety of patients before allowing workers to commence a caring role.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Care agencies who carry out a regulated activity must be registered by the Care Quality Commission (CQC) and are expected to comply with relevant regulations. Where a care agency does not carry out a regulated activity but supplies workers to a regulated care provider, the legal duty to comply with CQC regulations sits with the registered provider using the agency and the registered manager.
Regulation 19 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 sets out that it is the responsibility of the regulated provider to ensure robust and safe recruitment practices are in place, and to make sure that all staff, including agency staff, are suitably experienced, competent, and able to carry out their role. Further information on Regulation 19 is avaiable at the following link:
Registered providers are also expected to comply with Regulation 18: Staffing, which sets out a provider’s responsibility to deploy enough suitably qualified, competent, and experienced staff. Further information on Regulation 18 is avaiable at the following link:
The CQC can assess compliance with these regulations through assessment and monitoring activity. Where a breach of regulation or non-compliance is identified, the CQC can take regulatory action.
An Enhanced Disclosure and Barring Service (DBS) check must be undertaken prior to the recruitment of all care workers. In line with the CQC guidance for DBS checks, staff working with vulnerable adults can only start work before a DBS certificate is received if they have had a DBS Adult First Check, are appropriately supervised, and do not escort people away from the premises unless accompanied by someone with a DBS check.
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment the government has made of the potential impact of hospice cuts on quality of palliative care across the country.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Whilst the majority of palliative care and end-of-life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at the end of life and their loved ones.
Integrated care boards (ICBs) are responsible for commissioning palliative care and end-of-life care services that meet the needs of their local populations. To support ICBs in this duty, NHS England has published statutory guidance and service specifications. The statutory guidance states that ICBs must work to ensure that there is sufficient provision of care services to meet the needs of their local populations, which can include hospice services available within the ICB catchment.
NHS England has reinforced the requirement that, from April 2026, ICBs and relevant providers must have a full understanding of current and projected service utilisation and costs, including for those needing end-of-life care, to support sustainable planning. This will help systems to better assess local need and maintain quality of care.
The Government is also providing £125 million of capital funding for eligible adult, and children and young people’s hospices and we recently also confirmed approximately £80 million of revenue funding for the next three years for children and young people’s hospices in England.
Additionally, the Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England. It will drive improvements in access, quality, and sustainability, and support ICB to commission high-quality, personalised care. Through our MSF, we will closely monitor the shift towards the strategic commissioning of palliative care and end-of-life care services, and we will also consider contracting and commissioning arrangements.
Asked by: Roz Savage (Liberal Democrat - South Cotswolds)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the Care Quality Commission’s inspection capacity in Gloucestershire; and what steps are being taken to help ensure that people in (a) South Cotswolds constituency and (b) the UK have access to up-to-date and reliable inspection information when choosing care providers.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. Health is a devolved matter for the rest of United Kingdom.
The Department is aware of the need for the CQC to make improvements in the number of assessments it undertakes, following Dr Penny Dash’s review of the CQC’s operational effectiveness, published in October 2025.
The CQC is being supported and held to account for making improvements, including increasing the number of provider assessments and the timely publication of assessments reports.
Assessment reports are published on the CQC’s website and accessible to the public for information when choosing care providers.
From January 2026, the CQC will prioritise inspections of services with outdated ratings and those not previously assessed, while continuing to respond to risks. These steps aim to provide timely and reliable inspection information for individuals choosing care providers, including those in the South Cotswolds.
Asked by: Rebecca Paul (Conservative - Reigate)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he intends to publish the document entitled Pathways Trial for GnRHa - Guidance for CYPGS Clinicians.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
A document entitled PATHWAYS TRIAL for Gonadotropin Releasing Hormone Analogues (GnRHa) – Guidance for CYPGS clinicians is referenced in the published research protocol for the PATHWAYS study of puberty suppression. The Department does not hold a copy this document and would not expect to hold it, and therefore has no plans to publish it.
Asked by: Lewis Cocking (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with industry on the expansion of manufacturing sites for glioblastoma treatment development.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer provided on 22 December 2025 by the Department for Science, Innovation and Technology, to Question 99356.
Asked by: Lewis Cocking (Conservative - Broxbourne)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he plans to answer Question 99357, tabled on 11 December 2025.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the hon. Member to the answer I gave on 29 January 2026 to Question 99357.
Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to his Department's press release entitled £78bn for councils in turning point settlement to cut deprivation, published on 17 December 2025, what impact the National Care Service will have on single-tier authorities such as Thurrock Council.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are progressing towards a National Care Service based on higher quality of care, greater choice and control, and better join up between services, with approximately £4.6 billion of additional funding available for adult social care by 2028/29 compared to 2025/26.
We know that meaningful, lasting reform of adult social care across all tiers of local authority in England cannot be delivered overnight. To build consensus on plans for a National Care Service, Baroness Casey is chairing an Independent Commission into adult social care to shape the medium- and longer-term reforms needed, with phase 1 reporting later this year.
We have already been putting the core foundations for a National Care Service in place, aligned with the Government’s three objectives for adult social care, by improving the quality of care by valuing and supporting our vital care workforce, and by legislating for a Fair Pay Agreement backed by £500 million of funding. We are strengthening join-up between health and social care services by developing neighbourhood health services and reforming the Better Care Fund. We are also enabling people to have more choice and control over their care, for instance by promoting greater use of direct payments.
Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to his Department's press release entitled £78bn for councils in turning point settlement to cut deprivation, published on 17 December 2025, what impact the National Care Service will have on two-tier authority areas such as Basildon.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We are progressing towards a National Care Service based on higher quality of care, greater choice and control, and better join up between services, with approximately £4.6 billion of additional funding available for adult social care by 2028/29 compared to 2025/26.
We know that meaningful, lasting reform of adult social care across all tiers of local authority in England cannot be delivered overnight. To build consensus on plans for a National Care Service, Baroness Casey is chairing an Independent Commission into adult social care to shape the medium- and longer-term reforms needed, with phase 1 reporting later this year.
We have already been putting the core foundations for a National Care Service in place, aligned with the Government’s three objectives for adult social care, by improving the quality of care by valuing and supporting our vital care workforce, and by legislating for a Fair Pay Agreement backed by £500 million of funding. We are strengthening join-up between health and social care services by developing neighbourhood health services and reforming the Better Care Fund. We are also enabling people to have more choice and control over their care, for instance by promoting greater use of direct payments.
Asked by: Bob Blackman (Conservative - Harrow East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
There are established systems within the National Health Service to ensure that cumulative drug toxicity and polypharmacy risks are actively monitored in people prescribed sodium valproate. In practice, this involves establishing arrangements for assessing, reviewing, and monitoring the ongoing need for treatments, and, given that sodium valproate is almost invariably initiated in secondary care, clear shared-care arrangements between secondary and primary care clinicians, supported by the involvement of pharmacists, to minimise the risks associated with cumulative drug toxicity and polypharmacy.
Asked by: Sarah Pochin (Reform UK - Runcorn and Helsby)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent serum Clozapine blood samples from being lost in transit within the NHS.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
No specific assessment has been made of the reliability of current systems for transporting and processing serum Clozapine blood samples across National Health Service providers. Operational responsibility for the collection, transport, and processing of clozapine blood samples lies with individual NHS providers and their commissioned pathology and courier services. Further information on sample type and transport stability is available via individual NHS trust laboratory webpages.
Testing for clozapine levels is carried out within the same accredited pathology framework used for other biochemical assays, with defined requirements for sample collection, labelling, storage and transport to maintain sample integrity. Laboratories providing clozapine assays hold UKAS ISO 15189 accreditation and are required to undertake internal quality control and participate in national External Quality Assessment schemes to ensure accuracy and reproducibility of results.
Samples are transported through contracted courier services operating temperature controlled logistics, chain of custody processes and turnaround time requirements. These arrangements form part of routine clinical governance, incident reporting and performance management across NHS pathology services to prevent sample loss and provide assurance on the reliability of testing. Detailed operational arrangements are managed locally by individual pathology providers.